Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors.
Menez S, Kerr K, Cheng S, Hu D, Thiessen-Philbrook H, Moledina D, Mansour S, Go A, Ikizler T, Kaufman J, Kimmel P, Himmelfarb J, Coca S, Parikh C. Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors. Clinical Journal Of The American Society Of Nephrology 2024 PMID: 39671257, DOI: 10.2215/cjn.0000000622.Peer-Reviewed Original ResearchAcute kidney injurySoluble tumor necrosis factor receptor 1End-stage kidney diseaseChronic kidney diseaseKidney diseaseFollow-upPost-AKI careDevelopment of end-stage kidney diseaseKidney-specific outcomesYears of follow-upCombination of clinical variablesReceiver-operating characteristic curveTumor necrosis factor receptor 1Progression of kidney diseaseSequelae of acute kidney injuryAdverse kidney eventsAge of study participantsAcute kidney injury survivorsDiuretic useEGFR declineKidney disease riskKidney eventsAKI patientsKidney injuryPost-discharge follow-upUrinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease
de Cos M, Mosoyan G, Chauhan K, Troost J, Wong J, Lefferts S, Morgan P, Meliambro K, Egerman M, Ray J, Parker T, Levine D, Seshan S, Bardash Y, Horowitz B, Kent C, Shaw M, Perlman A, Moledina D, Coca S, Campbell K. Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease. American Journal Of Kidney Diseases 2024, 84: 205-214.e1. PMID: 38452919, PMCID: PMC11260534, DOI: 10.1053/j.ajkd.2024.01.520.Peer-Reviewed Original ResearchAssociated with end-stage kidney diseaseEnd-stage kidney diseaseUrinary plasmin(ogenGlomerular diseaseGlomerular disordersBiopsy-proven glomerular diseaseVariable clinical courseDevelopment of novel therapiesCohort of patientsRestricted to patientsElectro-chemiluminescence immunoassayHuman glomerular diseasesClinical courseUrinary markersUrine creatinineAbstractText Label="RATIONALENovel therapiesPrognostic decision makingCox regressionWhite patientsDisease progressionKidney diseasePatientsPodocyte injuryCohort